Study summary · research use only
Cardiogenetics and uncertainty: Evaluation of professional vulnerability in France
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This national online survey conducted in France, in collaboration with the CARDIOGEN network, examined how professionals involved in cardiogenetics care (clinical geneticists, genetic counselors, cardiologists, nurses, and psychologists) experience professional vulnerability. Of 86 respondents, 64% reported experiencing vulnerability, which was not correlated with profession, experience, or clinic organization. Reported vulnerabilities were mainly related to uncertainties around incomplete penetrance, variable expression, and genotype-phenotype disparities, compounded by evolving interpretation of genetic data and increased access to genomics. Concerns were heightened in cases of unexplained sudden death requiring genetic investigation and family follow-up. The abstract reports that vulnerability also reflected the need for specialized knowledge, structural complexities of combined genetics-cardiology teams, and professionals' capacity to empathize.
Abstract
Scientific advances in genomics are transforming healthcare and prevention. However, they also increase situations of uncertainty, which in turn increase vulnerability not only for patients and their families but also for professionals. Cardiogenetics plays a crucial role in preventing sudden death in young individuals, but it can pose complex challenges for healthcare teams. To study professionals' perspectives and experiences regarding cardiogenetics-related vulnerability, a national online survey was conducted in France to gather insight from professionals involved in the care pathway of individuals with cardiogenetic conditions. The survey targeted clinical geneticists, genetic counselors, cardiologists, nurses, and psychologists, in collaboration with the CARDIOGEN network. Out of 86 respondents, the majority (64%) reported experiencing vulnerability, which was not correlated with their profession, experience, or the organization of their clinics. Acknowledged vulnerabilities were mainly related to uncertainties regarding incomplete penetrance, variable expression, and genotype-phenotype disparities in cardiogenetics, exacerbated by the evolving interpretation of genetic data, due to the increased access to genomics. Additionally, the implications of these issues, particularly in cases of unexplained sudden deaths that necessitated genetic investigations and family follow up recommendations, raised further concerns. The reported vulnerabilities encompassed both the need for specialized knowledge and the structural complexities of teams combining skills in genetics and cardiology. In addition, the professionals' capacity to empathize can add a degree of vulnerability. Finally, it seems important to focus on how cardiogenetics teams are organized, particularly through close collaboration among genetics and cardiology units, which could help reduce this feeling of vulnerability.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.